The ADHD Medication Shortage: What to Know in 2026

Yes, for some products. The FDA first posted a shortage notice for amphetamine mixed salts (Adderall and its generics) on October 12, 2022, and the listing has remained open since. As of late 2026, the FDA Drug Shortages database still lists some stimulant products, including certain strengths and forms of amphetamine mixed salts and some methylphenidate products, as in shortage.

Generic immediate-release forms have generally been harder to find than brand-name or extended-release products, and inventory can change week to week at individual pharmacies. In shortage does not mean unavailable everywhere; it means the supply at some points in the chain is unreliable.

The causes overlap: a sustained rise in adult ADHD diagnoses and prescriptions, manufacturing and raw-material issues, and federal production quotas that took time to adjust. The DEA increased its d-amphetamine production quota by about 25 percent in October 2025 and set higher quotas for 2026, but quota increases take months to reach pharmacy shelves, so relief has been gradual.

Because demand and supply can shift at the same time, the shortage has improved for some products while others remain hard to find. That unpredictability is one reason staying in contact with your prescribing clinician matters more than ever.

Start with the pharmacy, not the medicine cabinet. Call before your prescription is sent and ask whether the exact medication, strength, and form are in stock. If not, ask about equivalent configurations, such as two lower-strength tablets for a single higher dose, since pharmacies often stock one form but not another. CHADD recommends confirming stock before the prescriber transmits a controlled-substance prescription, because these prescriptions cannot easily be transferred between pharmacies.

If your usual pharmacy cannot fill it, call several local pharmacies, including smaller and independently owned ones, and tell your clinician what you find. Timing matters: pharmacies that receive a controlled-substance stock shipment typically fill these prescriptions quickly once the medication arrives.

Only when made with a prescriber. Stimulant medications are not interchangeable milligram for milligram, and switching between extended-release and immediate-release products changes how the medication works across the day. A clinician may recommend a within-class switch, for example from one amphetamine product to a methylphenidate product, or a different dose form, and will usually want a follow-up to see how the change is working.

Non-stimulant options such as atomoxetine, viloxazine, guanfacine, and clonidine have generally remained available and are not subject to the same DEA quotas, but they are not identical to stimulants in onset, effect, or side-effect profile. Whether one fits depends on your symptoms, history, and treatment goals.

Do not borrow medication from someone else or buy it online. Counterfeit pills sold over the internet are a documented public safety problem, and sharing prescription medication is both unsafe and illegal. Instead, let your clinician know as soon as you cannot fill: they may be able to bridge the gap with a different dose or form, adjust timing, or help you line up a supply at another pharmacy.

Some people notice a return of ADHD symptoms or difficulty concentrating for a few days after stopping a stimulant, though stimulants generally do not require tapering the way some other medications do. Your prescriber can tell you what to expect in your situation and what to watch for.

If you have never been evaluated for ADHD but the pattern sounds familiar, adult ADHD evaluation begins with a careful clinical interview rather than a single test. If you already take medication, medication management includes troubleshooting availability, discussing dose forms, and planning alternatives with you rather than leaving you to navigate supply problems alone.

The practice serves patients in Austin and surrounding communities, with telehealth appointments available across Texas where clinically appropriate. You can request a consultation to discuss evaluation, medication management, or shortage-related questions.